Top Quality Tranexamic Acid Powder CAS 1197-18-8 CAS NO.1197-18-8

Xi'an ZB Biotech Co., Ltd is specialized in researching, producing and selling herbal extract and API powder, which are mainly used in nutraceutical, cosmetic, beverage and food additives etc.

Owing plant base, extracting and purifying in GMP workshop, concentrating on the quality and cost each link. That XAZB Biotech is aiming of benefiting the world with lowest price but best products.

We are keeping overcritical on the quality and persisting in the profession all the time. XAZB owns two standardized production workshops, advanced multifunction extractors and juice concentrate equipment, covering 12,000m2. annual dried material processed 950MT, monthly production ability 60MT. 32 scientists are in R&D team. We have strict QC standards and perfect quality guarantee system, GMP certified, also FDA, ISO9001 and Halal certified. 

We also build an integrative marketing center in Xi'an city, China, involving in research, test, sale and service. With full qualification and exporting experience, our products are widely sold to more than 40 countries from Europe, America, Southeast Asia, Oceania and so on

Tranexamic acid, also known as tranexamic acid, its chemical name is 4-aminomethylcyclohexanecarboxylic acid, and its trade name is toxamine. Tranexamic acid (tranexamic acid) is a synthetic amino acid antifibrinolytic drug, which can competitively inhibit the binding of fibrin lysine and plasmin, thereby inhibiting the cracking of fibrin clots and producing hemostatic effect. It is mainly used clinically Various hemorrhages caused by hyperfibrinolysis. Tranexamic acid is a synthetic lysine analog that can competitively bind to the lysine binding site on plasminogen and plasmin, thereby competitively inhibiting the degradation of fibrin and reducing fibrinolytic activity , play a procoagulant effect. Theoretically, the use of tranexamic acid can lead to insufficient fibrinolytic activity, which in turn may lead to an increased risk of postoperative thrombotic events.

Tranexamic acid, a synthetic derivative of lysine, belongs to the class of antifibrinolytics with hemostatic properties.